BioLineRX Ltd BLRX
Key Stats
- Today's Range
- $2.73 – $2.93
- 50-Day Range
- $2.60 – $3.60
- 52-Week Range
- $2.15 – $4.75
- Volume
- 2K shs
- Average Volume
- 9K shs
- Market Cap
- $12.40 million
- P/E Ratio
- —
- Dividend Yield
- —
Short Interest
- Short Interest
- 12.43%
- Days to Cover
- 1.00
About BioLineRX Ltd
BioLine Rx Ltd is a commercial-stage biopharmaceutical company focused on oncology. The company's current development and commercialization pipeline consists of two clinical-stage therapeutic candidates motixafortide (BL-8040), a novel peptide for the treatment of stem-cell mobilization and solid tumors, and AGI-134, an immuno-oncology agent in development for solid tumors. In addition, the company has a legacy therapeutic product called BL-5010 for the treatment of skin lesions. The company has generated revenues from milestone payments under previously existing out-licensing agreements.
Related Stocks
Compare head-to-head: BLRX vs NVDA·BLRX vs AAPL·BLRX vs GOOGL·BLRX vs GOOG
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.